SGYP Related StreetInsider.com Reports
-
Unusual 11 Mid-Day Movers 04/11: (ACAD) (STP) (RAD) Higher; (NTIC) (LEDS) (FTNT) Lower
-
StreetInsider.com Pre-Open Movers 4/11: (ACAD) (AMRS) (RAD) Higher; (FTNT) (HPQ) (MSFT) Lower (more...)
-
Synergy Pharmaceuticals (SGYP) Prices 16.375M Shares at $5.50/Sh
-
Unusual 11 Mid-Day Movers 04/10: (IFMI) (DRWI) (STP) Higher; (HMA) (TITN) (HBIO) Lower
-
StreetInsider.com Pre-Open Movers 4/10: (WOR) (YHOO) (FB) Higher; (TITN) (HMA) (FSLR) Lower (more...)
-
Streetinsider.com After-Hours Movers 4/09: (WOR) (PSMT) Higher; (HMA) (RLGY) (THC) Lower (more...)
-
Synergy Pharma (SGYP) Announces $90M Common Offering
-
Unusual 11 Mid-Day Movers 01/02: (ZIP) (BIOF) (STXS) Higher; (SKUL) (DOLE) (NTLS) Lower
-
Synergy Pharmaceuticals (SGYP) PT Nearly Doubled at Cantor Fitzgerald
-
StreetInsider.com Pre-Open Movers 01/02: (ZIP) (MCP) (ANN) Higher; (SKUL) (TGT) (ANN) Lower (more...)
-
Synergy (SGYP) Higher After Plecanatide Meets Endpoints
-
Unusual 11 Mid-Day Movers 11/14: (ANF) (MEIP) (SGYP) Higher; (ORCC) (IAG) (ENVI) Lower
-
Synergy Pharma (SGYP) Reports Q3 Loss of 15c
-
Synergy Pharma (SGYP) Initiates SP-333 Phase I in UC
-
Notable Analyst Rating Changes 09/25: (SWY) (GFI) (TIVO) Upgraded; (PAYX) (LEN) (ADP) Downgraded
-
Cantor Fitzgerald Starts Synergy Pharmaceuticals (SGYP) at Buy
-
Synergy Pharma (SGYP) Files IND for SP-333
-
Streetinsider.com's Hot Lunchtime Reads 08/30: (YGE) (FB) (SGYP) (S) (YELP)
-
UPDATE: Synergy Pharma (SGYP) Higher on Linzess Approval (IRWD) (FRX)
-
Synergy Pharma (SGYP) Files $250M Mixed Shelf
-
Aegis Starts SGYP, IRWD, AMRN, MDVN at Buy, PLX at Hold
-
Synergy Pharmaceuticals (SGYP) Underwriters Execrcise Over-Allotment in 10M Offering
-
Synergy Pharma (SGYP) Reports Partial Exercise of Over-Allotment Option, Sees Proceeds of $48.4M
-
Unusual 11 Mid-Day Movers 05/04: (DGI) (SPRD) (DLB) Higher; (BODY) (INVN) (SGYP) Lower
-
Pre-Open Movers 5/4: (BAGL) (DLB) (DGI) Higher; (BODY) (ALXA) (CBOU) Lower (more...)
-
Synergy (SGYP) Prices 10M Offering at $4.50/Share
-
Synergy (SGYP) Hits Halfway Enrollment Milestone in Plecanatide Phase II/III
-
Roth Capital Starts Synergy Pharmaceuticals (SGYP) at Buy
-
Brean Murray Carret & Co. Starts Synergy Pharmaceuticals (SGYP) at Buy; Second to Start, But Looking To Finish First
-
Summer Street Starts Synergy Pharmaceuticals (SGYP) at Buy
-
Synergy Pharma (SGYP) Reports In-Line Q4 EPS
-
Morgan Joseph Starts Synergy Pharmaceuticals (SGYP) at Buy; Cracking Chronic Constipation
-
Global Hunter Securities Initiates Coverage on Synergy Pharmaceuticals (SGYP) with an Accumulate
Back to SGYP Stock Lookup
